Experts discuss Duchenne muscular dystrophy's pathophysiology, disease progression, and innovative treatment options to enhance patient care and outcomes.
Carol Wittlieb-Weber, MD
Advertisement
Articles by Carol Wittlieb-Weber, MD
Experts discuss Duchenne muscular dystrophy's pathophysiology, disease progression, and innovative treatment options to enhance patient care and outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis
2
Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease
3
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
4
CMSC 2026: Looking Ahead to the 40th Annual Meeting of the Consortium of MS Centers
5